Breaking News

PAREXEL Appoints SVP and CFO

June 14, 2013

Bank brings global experience

Ingo Bank has been appointed senior vice president at PAREXEL and will become chief financial officer on September 1. He joins the company from Royal Philips, where he served as chief financial officer and executive vice president of Philips Healthcare. Mr. Bank will be based at the company's corporate headquarters in Waltham, MA. He succeeds outgoing James F. Winschel, Jr., who will serve as executive vice president until he retires in 2014.
 
"PAREXEL is pleased to welcome a leader with Ingo's global experience.  He has an impressive record overseeing financial management across a variety of industry sectors. Ingo's business acumen and focus on continuous improvement and performance will serve us well as we drive our growth strategy and focus on continuing to deliver profitable results to our stakeholders," said Josef von Rickenbach, chairman and chief executive officer, PAREXEL.
 
"As we welcome Ingo Bank to PAREXEL, I would also like to recognize Jim Winschel's commitment to overseeing the worldwide financial management for the Company. Under his leadership, PAREXEL's market capitalization grew from $225 million to $2.7 billion, service revenue increased from $378 million to $1.7 billion and backlog grew from $385 million to over $4 billion," said Mr. von Rickenbach. "We thank Jim for his efforts and his continued involvement in the company."
blog comments powered by Disqus
  • Patent Law  and Contract Manufacturing

    Patent Law and Contract Manufacturing

    Beverly W. Lubit, Member of the Firm, Chiesa Shahinian & Giantomasi||September 8, 2016
    Analyzing the impact of The Medicines Co. vs. Hospira Inc. decision

  • The Impact of Sample Handling  and Processing on the Outcome of Bioanalytical Testing

    The Impact of Sample Handling and Processing on the Outcome of Bioanalytical Testing

    Haiko Pillu, Head Technical Operations, Life Science Services, SGS Belgium NV||September 8, 2016
    Optimizing bioanalytical procedures to get reliable results in clinical studies

  • Quality Risk Management

    Quality Risk Management

    Cheryl Abernathy and Bryan Sasbon, Quality Assurance Operations Manager, Ropack Pharma Solutions; QA Director & Regulatory Affairs, Ropack Pharma Solutions||September 8, 2016
    Embracing the process as a means to a strong quality culture